Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a Japanese hospital claims database

BACKGROUND: Current treatment for frequently relapsing, steroid-dependent, or steroid-resistant nephrotic syndrome focuses on immunosuppressive therapies. Although the clinical guideline suggests the use of mycophenolate mofetil (MMF), limited information is available on patients with primary nephro...

Descripción completa

Detalles Bibliográficos
Autores principales: Funatogawa, Takashi, Narita, Yusuke, Tamura, Aya, Mii, Kazuma, Sugitani, Yasuo, Uchida, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481489/
https://www.ncbi.nlm.nih.gov/pubmed/35579722
http://dx.doi.org/10.1007/s10157-022-02233-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481489/
https://www.ncbi.nlm.nih.gov/pubmed/35579722
http://dx.doi.org/10.1007/s10157-022-02233-w

Ejemplares similares